Market-making
Pricing and inventory management connect the quote offered to the exposure Drovix takes as principal.
Examine pricing and riskDrovix / Institutional liquidity / The bilateral relationshipInside institutional trading
Institutional liquidity.
Drovix on the other side.
A principal liquidity provider with its own market-making and bridge technology. Your institution brings the mandate; Drovix provides the agreed pricing, execution and connection.
The bilateral relationship / Who does what
Two parties.
Explicit responsibilities.
Select either side—or the agreement between them. See what Drovix contributes and which responsibilities remain with your institution.
Select a responsibility / conceptual bilateral model
Bilateral OTC
principal transaction
principal transaction
Drovix
Provide principal liquidity and the technology behind it.
Drovix develops market-making and bridge technology to support institutional pricing and execution. It prices as principal and manages the resulting exposure inside the agreed counterparty framework.
- Counterparty pricing and approved execution scope
- Market-making and exposure management
- The agreed connection and execution-reporting interface
Scope / What is agreed for your institution
Define the markets.
Define the terms.
Institutional liquidity is configured around the counterparty. These are the decisions to bring into the first conversation.
01Markets & instruments
Review FX, precious metals, energies, equity indices and other approved instruments against your mandate. Coverage, trading sessions and availability depend on the instrument, jurisdiction and agreed relationship.
Explore instrument coverage02Credit & margin
Counterparty credit limits, collateral and margin arrangements are agreed through onboarding and the institutional services agreement. Risk review defines the scope of the relationship and the applicable limits.
03Connectivity & order workflow
Scope FIX 4.4, REST, WebSocket or approved MT5 bridge connectivity around your existing systems. Define session requirements, order workflows, reconciliation and operational responsibilities before UAT.
04Reporting & review
Agree the execution reports, exposure summaries and transaction cost analysis required by your desk. Reporting supports your own risk, operations and best-execution review; schedules and scope are set per relationship.
The Drovix contribution
The price.
The bridge.
The principal.
Drovix combines a principal liquidity relationship with its own market-making and connectivity technology. Each part has a specific role in the institutional execution arrangement.
Bridge technology
Connect approved institutional infrastructure to the agreed pricing, order and reporting interfaces.
Explore the architectureCounterparty framework
Credit, margin and permitted instruments are established through counterparty review and written terms.
Review institutional eligibilityThe next conversation
Define your liquidity requirements.
Start with your instruments, connectivity and reporting requirements. The institutional desk will discuss the scope of a potential relationship.
Discuss institutional accessLeveraged OTC products, including Forex and CFDs, carry a high level of risk and a counterparty may lose more than its initial margin. The Drovix offering is directed exclusively at Eligible Counterparties and Professional Clients; Drovix does not provide services to retail clients.
Scope. Drovix provides bilateral OTC liquidity as principal. Drovix is not a public exchange, MTF, OTF or ECN and does not match third-party orders on a multilateral venue.
Important. Drovix provides services only to professional clients, eligible counterparties and institutional clients where permitted by applicable law. Drovix does not provide services to retail clients, does not accept retail deposits and does not offer retail trading accounts. Regulatory authorisations apply only to the specific legal entity to which they are granted and do not extend automatically to any affiliated entity, group company or brand.